Our study was conducted before this classification was implemented and all groups include patients with tumors classified as IDH-mutant glioblastoma which would now be classified as IDH-mutant astrocytoma (grade 4). The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).